ResearchMoz

United States Non-Vascular Stents Market Outlook to 2020

GlobalData
Published Date » 2014-07-14
No. Of Pages » 109
   
 GlobalDatas new report, "United States Non-Vascular Stents Market Outlook to 2020", provides key market data on the United States Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate...
Table of Content

1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5

2 Introduction 7
2.1 What Is This Report About? 7
2.2 Non-Vascular Stents Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8

3 Non-Vascular Stents Market, United States 11
3.1 Non-Vascular Stents Market, United States, Revenue ($m), 2005-2013 11
3.2 Non-Vascular Stents Market, United States, Revenue ($m), 2013-2020 13
3.2.1 Biliary Stents Market, United States, Revenue ($m), by Segment, 2005-2013 15
3.2.1.1 Metal Biliary Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 17
3.2.2 Gastrointestinal Stents Market, United States, Revenue ($m), by Segment, 2005-2013 19
3.2.3 Airway Stents Market, United States, Revenue ($m), by Segment, 2005-2013 21
3.2.3.1 Metallic Airway Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 23
3.2.4 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2005-2013 25
3.2.4.1 Prostate Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 27
3.2.4.2 Ureteral Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 29
3.2.4.3 Urethral Stents Market, United States, Revenue ($m), by Sub Segment, 2005-2013 31
3.2.5 Biliary Stents Market, United States, Revenue ($m), by Segment, 2013-2020 33
3.2.5.1 Metal Biliary Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 35
3.2.6 Gastrointestinal Stents Market, United States, Revenue ($m), by Segment, 2013-2020 37
3.2.7 Airway Stents Market, United States, Revenue ($m), by Segment, 2013-2020 39
3.2.7.1 Metallic Airway Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 41
3.2.8 Urinary Tract Stents Market, United States, Revenue ($m), by Segment, 2013-2020 43
3.2.8.1 Prostate Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 45
3.2.8.2 Ureteral Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 47
3.2.8.3 Urethral Stents Market, United States, Revenue ($m), by Sub Segment, 2013-2020 49
3.3 Non-Vascular Stents Market, United States, Volume (Units), 2005-2013 51
3.4 Non-Vascular Stents Market, United States, Volume (Units), 2013-2020 53
3.4.1 Biliary Stents Market, United States, Volume (Units), by Segment, 2005-2013 55
3.4.1.1 Metal Biliary Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 57
3.4.2 Gastrointestinal Stents Market, United States, Volume (Units), by Segment, 2005-2013 59
3.4.3 Airway Stents Market, United States, Volume (Units), by Segment, 2005-2013 61
3.4.3.1 Metallic Airway Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 63
3.4.4 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2005-2013 65
3.4.4.1 Prostate Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 67
3.4.4.2 Ureteral Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 69
3.4.4.3 Urethral Stents Market, United States, Volume (Units), by Sub Segment, 2005-2013 71
3.4.5 Biliary Stents Market, United States, Volume (Units), by Segment, 2013-2020 73
3.4.5.1 Metal Biliary Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 75
3.4.6 Gastrointestinal Stents Market, United States, Volume (Units), by Segment, 2013-2020 77
3.4.7 Airway Stents Market, United States, Volume (Units), by Segment, 2013-2020 79
3.4.7.1 Metallic Airway Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 81
3.4.8 Urinary Tract Stents Market, United States, Volume (Units), by Segment, 2013-2020 83
3.4.8.1 Prostate Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 85
3.4.8.2 Ureteral Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 87
3.4.8.3 Urethral Stents Market, United States, Volume (Units), by Sub Segment, 2013-2020 89
3.5 Non-Vascular Stents Market, United States, Average Price ($), 2005-2020 91
3.6 Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), 2012-2013 95
3.7 Non-Vascular Stents Market, United States, Company Share by Revenue ($m), 2012-2013 96

4 Overview of Key Companies in United States, Non-Vascular Stents Market 98
4.1 Boston Scientific Corporation 98
4.1.1 Company Overview 98
4.2 Cook Group Incorporated 98
4.2.1 Company Overview 98
4.3 C. R. Bard, Inc. 98
4.3.1 Company Overview 98
4.4 Covidien plc 99
4.4.1 Company Overview 99
4.5 Applied Medical Corporation 99
4.5.1 Company Overview 99
4.6 Taewoong Medical Co.,Ltd. 99
4.6.1 Company Overview 99
4.7 Olympus Corporation 100
4.7.1 Company Overview 100
4.8 ConMed Corporation 100
4.8.1 Company Overview 100
4.9 Merit Medical Systems, Inc. 100
4.9.1 Company Overview 100

5 Appendix 101
5.1 Research Methodology 102
5.1.1 Coverage 102
5.1.2 Secondary Research 102
5.1.3 Primary Research 103
5.1.4 Market Modeling and Forecasting 104
5.1.5 Company Share Analysis 107
5.1.6 Distribution Share Analysis 108
5.2 Expert Panel 108
5.3 GlobalData Consulting 109
5.4 Contact Us 109
5.5 Disclaimer 109

List of Tables


Table 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 12
Table 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 14
Table 3: Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 16
Table 4: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 18
Table 5: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 20
Table 6: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 22
Table 7: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 24
Table 8: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 26
Table 9: Prostate Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 28
Table 10: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 30
Table 11: Urethral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 32
Table 12: Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 34
Table 13: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 36
Table 14: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 38
Table 15: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 40
Table 16: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 42
Table 17: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 44
Table 18: Prostate Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 46
Table 19: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 48
Table 20: Urethral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 50
Table 21: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2005-2013 52
Table 22: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2013-2020 54
Table 23: Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 56
Table 24: Metal Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 58
Table 25: Gastrointestinal Stents Market, United States, Volume (Units), Historic, 2005-2013 60
Table 26: Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 62
Table 27: Metallic Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 64
Table 28: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2005-2013 66
Table 29: Prostate Stents Market, United States, Volume (Units), Historic, 2005-2013 68
Table 30: Ureteral Stents Market, United States, Volume (Units), Historic, 2005-2013 70
Table 31: Urethral Stents Market, United States, Volume (Units), by Sub Segment, Historic, 2005-2013 72
Table 32: Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 74
Table 33: Metal Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 76
Table 34: Gastrointestinal Stents Market, United States, Volume (Units), Forecast, 2013-2020 78
Table 35: Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 80
Table 36: Metallic Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 82
Table 37: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2013-2020 84
Table 38: Prostate Stents Market, United States, Volume (Units), Forecast, 2013-2020 86
Table 39: Ureteral Stents Market, United States, Volume (Units), Forecast, 2013-2020 88
Table 40: Urethral Stents Market, United States, Volume (Units), Forecast, 2013-2020 90
Table 41: Non-Vascular Stents Market, United States, Average Price ($), Historic, 2005-2013 91
Table 42: Non-Vascular Stents Market, United States, Average Price ($), Forecast, 2013-2020 93
Table 43: Non-Vascular Stents Market, United States, Distribution Share by Revenue ($m), USD Constant, 2012-2013 95
Table 44: Non-Vascular Stents Market, United States, Company Share by Revenue ($m), USD Constant, 2012-2013 97
Table 45: Total Number of Primary Research Participants, General Surgery Market, by Country 104

List of Figures


Figure 1: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 11
Figure 2: Non-Vascular Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 13
Figure 3: Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 15
Figure 4: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 17
Figure 5: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 19
Figure 6: Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 21
Figure 7: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 23
Figure 8: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 25
Figure 9: Prostate Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 27
Figure 10: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 29
Figure 11: Urethral Stents Market, United States, Revenue ($m), USD Constant, Historic, 2005-2013 31
Figure 12: Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 33
Figure 13: Metal Biliary Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 35
Figure 14: Gastrointestinal Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 37
Figure 15: Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 39
Figure 16: Metallic Airway Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 41
Figure 17: Urinary Tract Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 43
Figure 18: Prostate Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 45
Figure 19: Ureteral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 47
Figure 20: Urethral Stents Market, United States, Revenue ($m), USD Constant, Forecast, 2013-2020 49
Figure 21: Non-Vascular Stents Market, United States, Volume (Units), Historic, 2005-2013 51
Figure 22: Non-Vascular Stents Market, United States, Volume (Units), Forecast, 2013-2020 53
Figure 23: Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 55
Figure 24: Metal Biliary Stents Market, United States, Volume (Units), Historic, 2005-2013 57
Figure 25: Gastrointestinal Stents Market, United States, Volume (Units), Historic, 2005-2013 59
Figure 26: Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 61
Figure 27: Metallic Airway Stents Market, United States, Volume (Units), Historic, 2005-2013 63
Figure 28: Urinary Tract Stents Market, United States, Volume (Units), Historic, 2005-2013 65
Figure 29: Prostate Stents Market, United States, Volume (Units), Historic, 2005-2013 67
Figure 30: Ureteral Stents Market, United States, Volume (Units), Historic, 2005-2013 69
Figure 31: Urethral Stents Market, United States, Volume (Units), Historic, 2005-2013 71
Figure 32: Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 73
Figure 33: Metal Biliary Stents Market, United States, Volume (Units), Forecast, 2013-2020 75
Figure 34: Gastrointestinal Stents Market, United States, Volume (Units), Forecast, 2013-2020 77
Figure 35: Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 79
Figure 36: Metallic Airway Stents Market, United States, Volume (Units), Forecast, 2013-2020 81
Figure 37: Urinary Tract Stents Market, United States, Volume (Units), Forecast, 2013-2020 83
Figure 38: Prostate Stents Market, United States, Volume (Units), Forecast, 2013-2020 85
Figure 39: Ureteral Stents Market, United States, Volume (Units), Forecast, 2013-2020 87
Figure 40: Urethral Stents Market, United States, Volume (Units), Forecast, 2013-2020 89
Figure 41: Non-Vascular Stents Market, United States, Company Share (%), 2013 96
Figure 42: GlobalData Epidemiology-Based Forecasting Model 106
Figure 43: GlobalData Capital Equipment-Based Forecasting Model 107
Figure 44: Primary Interviews by Participant Type (%) 108

Upcoming Reports:

Poland: men shirts market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the men shirts market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the men shirts market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Poland: zinc oxide (white) market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the zinc oxide market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the zinc oxide market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the...
Poland: carpets market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the carpets market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the carpets market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Nuclear Development Plans in China Gets Fresh Impetus
Mar 5, 2015  
The nuclear development plans of China got a renewed momentum on Wednesday as State Council gave a nod to build new reactors at the nuclear power plant located near Hongyan River. The unit 5 and 6 of the nuclear plant near Hongyan River, located in the northeastern province of Liaoning got approval for construction from the State Council. The council also mentioned that the construction should...
Indian Telecoms Bid at Spectrum War
Mar 5, 2015  
The Indian government on Wednesday managed to mop up nearly INR 60,000 crore with the spectrum auctions off to a wonderful start. Top bidders included Idea Cellular, Bharti Airtel, and Vodafone India who fought tooth and nail to gain secure airwaves in those areas where their licenses were nearing expiration. Reliance Jio Infocomm made a strenuous attempt to acquire as many data airwaves as...
South Korean Pharmaceutical Companies Extend Business with Saudi Arabia
Mar 5, 2015  
Four South Korean pharmaceutical companies will export their products to Saudi Arabia, including anticancer drugs and antibiotics, for the coming five years, South Korea’s Health Ministry informed this Wednesday, as a result of South Korean President Park Geun-hye's business trip to the Saudi Arabia this week. Ascertaining to the export agreement, representatives of these four Korean...
U.K. Government Slow to Stop Pharma R&D Slump
Mar 4, 2015  
When it comes to turnaround strategies, the focal point of the U.K. government is currently the life sciences industry. Recent data however shows that healthcare companies are spending less and less on research and development processes on drugs in the country. The Office of National Statistics released the data earlier this week. It shows the United Kingdom’s drug production...
Sun Pharma Buys Out GSK Australian Opiates Business
Mar 4, 2015  
Global pharmaceutical giant GSK announced on Tuesday that they had come to an agreement with Sun Pharmaceuticals Industries for the latter to buy out the opiates business in Australia owned by GSK. A joint statement was made by the two pharma top companies. The statement said that the companies’ respective wholly owned subsidiaries had already come to an agreement that was...